OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
4
Results
Show all
Save search
Copy query
Show results for
Unknown
(2)
Proteomics
(2)
Organisms
Homo sapiens
(1)
Mus musculus
(1)
Repository
iProX
(1)
pride
(1)
Tissue
Cell culture
(1)
Fibroblast
(1)
Technology Type
Gel-based experiment
(1)
Mass Spectrometry
(1)
Publication Date
2021
(1)
2025
(1)
Release Date
2025
(1)
2024
(1)
Lab affiliation
The First Affiliated Hospital of Chongqing Medical University
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Identification of AEBP1-binding proteins
Identification of AEBP1-binding proteins, gel-based proteomics
ORGANISM(S):
Mus musculus (Mouse)
2025-08-15
|
PXD067349
|
Pride
Aebp1 ckap4
Cite
Switch to fixed-dose ainuovirine, lamivudine, and tenofovir DF
versus
elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed people living with HIV-1: the 48-week results of the SPRINT trial, a multi-centre, randomised, double-blind, active-controlled, phase 3, non-inferiority trial.
Not available
S-EPMC11293588
|
biostudies-literature
Cite
Immediate and delayed switches to tenofovir DF-containing, ainuovirine-based antiretroviral regimen: the SPRINT extensional study.
Not available
S-EPMC12482040
|
biostudies-literature
Cite
ARIH1 Signaling Promotes Anti-tumor Immunity by Targeting PD-L1 for Proteasomal Degradation
We find EGFR inhibitors promote PD-L1 ubiquitination and proteasomal degradation following GSK3α-mediated phosphorylation of Ser279/Ser283.
ORGANISM(S):
Homo Sapiens
2021-03-01
|
PXD024452
|
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets